Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Republic Services
RSG
$67.4B
| $52.6M | 0.03% |
641,619
-2,436
| -0.4% | -$196K |
|
|
NBIS
477
Nebius Group N.V.
NBIS
$37.6B
| $52.4M | 0.03% |
1,047,306
-49,074
| -4% | -$1.97M |
|
478
WEC Energy
WEC
$36.3B
| $52M | 0.03% |
593,644
-41,329
| -7% | -$3.73M |
|
479
Phathom Pharmaceuticals
PHAT
$928M
| $52M | 0.03% |
1,578,679
-88,898
| -5% | -$3.42M |
|
480
Churchill Downs
CHDN
$6.17B
| $51.9M | 0.03% |
779,676
-29,380
| -4% | -$1.67M |
|
481
Qorvo
QRVO
$7.9B
| $51.8M | 0.03% |
468,495
-227,707
| -33% | -$22.6M |
|
482
Bank of Hawaii
BOH
$3.14B
| $51.6M | 0.03% |
841,046
-132,724
| -14% | -$8.2M |
|
|
RDFN
483
DELISTED
Redfin
RDFN
| $51.6M | 0.03% |
1,231,373
-4,694
| -0.4% | -$124K |
|
484
American International
AIG
$42.5B
| $51.4M | 0.03% |
1,648,804
-1,884,056
| -53% | -$52.9M |
|
485
Check Point Software Technologies
CHKP
$14.3B
| $51.1M | 0.03% |
475,252
+49,414
| +12% | +$5.24M |
|
|
CMD
486
DELISTED
Cantel Medical Corporation
CMD
| $51M | 0.03% |
1,152,009
-397,646
| -26% | -$14.8M |
|
487
Xylem
XYL
$28.5B
| $50.8M | 0.03% |
781,395
+306,755
| +65% | +$20.2M |
|
|
CONE
488
DELISTED
CyrusOne Inc Common Stock
CONE
| $50.7M | 0.03% |
696,957
-729,272
| -51% | -$51.9M |
|
489
Trane Technologies
TT
$98.8B
| $50M | 0.03% |
562,025
-1,372,865
| -71% | -$119M |
|
490
Encompass Health
EHC
$11.3B
| $49.8M | 0.03% |
1,010,016
-131,868
| -12% | -$7.12M |
|
491
TriNet
TNET
$3.23B
| $49.7M | 0.03% |
815,236
-33,008
| -4% | -$1.65M |
|
492
Steven Madden
SHOO
$3.17B
| $49.5M | 0.03% |
2,006,583
+781,997
| +64% | +$18.3M |
|
|
MNTA
493
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $49.5M | 0.03% |
1,488,914
+1,472,872
| +9,181% | +$46.9M |
|
|
B
494
Barrick Mining
B
$60.9B
| $49.2M | 0.03% |
1,832,685
-1,630,769
| -47% | -$40.7M |
|
495
Janus Henderson Short Duration Income ETF
VNLA
$3.34B
| $48.6M | 0.03% |
966,734
-821,340
| -46% | -$40.9M |
|
|
MDLA
496
DELISTED
Medallia, Inc.
MDLA
| $48.4M | 0.03% |
1,917,211
+119,719
| +7% | +$2.86M |
|
497
Okta
OKTA
$23.8B
| $48M | 0.03% |
239,682
-199,008
| -45% | -$33.8M |
|
498
Avery Dennison
AVY
$12.8B
| $47.9M | 0.03% |
419,572
-100,783
| -19% | -$11.1M |
|
|
KSU
499
DELISTED
Kansas City Southern
KSU
| $47.7M | 0.03% |
319,530
-265,641
| -45% | -$37.3M |
|
500
MarketAxess Holdings
MKTX
$4.47B
| $47.6M | 0.03% |
95,069
-184,637
| -66% | -$86M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.